IRWD stock forecast
Our latest prediction for Ironwood Pharmaceuticals, Inc.'s stock price was made on the Feb. 24, 2020 when the stock price was at 11.28$.
In the short term (2weeks), IRWD's stock price should underperform the market by -2.31%. During that period the price should oscillate between -8.21% and +7.83%.
In the medium term (3months), IRWD's stock price should underperform the market by -7.53%. During that period the price should oscillate between -30.26% and +19.31%.Get email alerts
About Ironwood Pharmaceuticals, Inc.
Ironwood Pharmaceuticals, Inc. is a commercial biotechnology company, which engages in the discovery, commercialization, and development of medicines. Its products include linaclotide, a guanylate cyclase type-C agonists which treats patients irritable bowel syndrome with constipation and chronic constipation. The company was founded by Peter M. Hecht, Eric F. Summers, G. Todd Milne, Brian M. Cali, Joseph C. Cook Jr., and Gina Bornino Miller on January 5, 1998 and is headquartered in Boston, MA.
At the moment the company generates 428M USD in revenues.
On its last earning announcement, the company reported a profit of 0.14$ per share.
The book value per share is -0.28$
Three months stock forecastFeb. 24, 2020
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|